Related references
Note: Only part of the references are listed.QSAR and QSPR Model Interpretation Using Partial Least Squares (PLS) Analysis
David T. Stanton
Current Computer-Aided Drug Design (2012)
Discovery of Dual Inducible/Neuronal Nitric Oxide Synthase (iNOS/nNOS) Inhibitor Development Candidate 4-(2-Cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) Part 2: Identification of a Novel, Potent, and Selective Series of Benzimidazole-Quinolinone iNOS/nNOS Dimerization Inhibitors That Are Orally Active in Pain Models
Joseph E. Payne et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome
Anna J. Dare et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Nitric oxide, chronic inflammation and autoimmunity
Gyorgy Nagy et al.
IMMUNOLOGY LETTERS (2007)
3D QSAR methods: Phase and catalyst compared
David A. Evans et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors
David D. Davey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Steven L. Dixon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
Antinociceptive activity of the selective iNOS inhibitor AR-C102222 in rodent models of inflammatory, neuropathic and post-operative pain
Christopher J. LaBuda et al.
EUROPEAN JOURNAL OF PAIN (2006)
PHASE: A novel approach to pharmacophore modeling and 3D database searching
Steven L. Dixon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo
WK Alderton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Pharmacological profile of FR260330, a novel orally active inducible nitric oxide synthase inhibitor
N Chida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
PPA250 [3-(2,4-difluorophenyl)-6-{2-[4-(1H-imidazol-1-ylmethyl)phenoxy]ethoxy}-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of chronic arthritis
M Ohtsuka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Neural roles for heme oxygenase:: Contrasts to nitric oxide synthase
DE Barañano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
GA Kaminski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
Nitric oxide and atherosclerosis
C Napoli et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2001)
Inducible nitric oxide synthase: a little bit of good in all of us
P Kubes
GUT (2000)
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry
K McMillan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)